Covid Express Testing INC
Covid Express Testing INC was paid $104K by Medicaid between Mar 2022 and Aug 2023, across 10 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 34% of everything it billed.
33Billing provider infoCOVID EXPRESS TESTING INC
MIDDLE VLG, NY 11379
MIDDLE VLG, NY 11379
33aNPI1598414476assigned 03/19/2022
33bProvider typeCommunity Health Worker
28Total paid$104K
24GClaims5,168
24DCodes billed10
24AFirst – last monthMar 2022 – Aug 2023
Compared with peers
Next to other Community Health Worker providers in New York
Rank by total paid#6 of 7
Median peer was paid$981K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 3,408 | $71K | |
| 2023 | 1,760 | $33K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 34% | 852 | 651 | $35K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 29% | 915 | 725 | $30K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 17% | 172 | 148 | $18K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 11% | 231 | 166 | $12K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 3.7% | 760 | 620 | $4K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.6% | 35 | 33 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 987 | 731 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,097 | 830 | $176.94 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 76 | 73 | $80.00 |
| 99051 | 0% | 43 | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKANDOV, LEANA (OWNER)
| Provider | Location | Paid |
|---|---|---|
| D&S Pharmacy LLC | Middle Village, NY | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.